{"id":"https://openalex.org/W4381737962","doi":"https://doi.org/10.2337/db23-1802-pub","title":"1802-PUB: Liraglutide as a Potential Drug Repurposing Candidate for Alzheimer\u2019s Disease and Related Dementia\u2014Real-World Evidence","display_name":"1802-PUB: Liraglutide as a Potential Drug Repurposing Candidate for Alzheimer\u2019s Disease and Related Dementia\u2014Real-World Evidence","publication_year":2023,"publication_date":"2023-06-23","ids":{"openalex":"https://openalex.org/W4381737962","doi":"https://doi.org/10.2337/db23-1802-pub"},"language":"en","primary_location":{"id":"doi:10.2337/db23-1802-pub","doi":"https://doi.org/10.2337/db23-1802-pub","is_oa":false,"landing_page_url":"http://dx.doi.org/10.2337/db23-1802-pub","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101902551","display_name":"Tiansheng Wang","orcid":"https://orcid.org/0000-0002-0980-8896","observed_orcids":["https://orcid.org/0000-0002-0980-8896"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TIANSHENG WANG","raw_affiliation_strings":["Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chapel Hill, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040182038","display_name":"John B. Buse","orcid":"https://orcid.org/0000-0002-9723-3876","observed_orcids":["https://orcid.org/0000-0002-9723-3876","https://orcid.org/0000-0001-6894-4110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"JOHN B. BUSE","raw_affiliation_strings":["Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chapel Hill, NC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036291591","display_name":"Virginia Pate","orcid":"https://orcid.org/0000-0002-2141-8882","observed_orcids":["https://orcid.org/0000-0002-2141-8882"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"VIRGINIA PATE","raw_affiliation_strings":["Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chapel Hill, NC","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043069598","display_name":"Til St\u00fcrmer\u200e","orcid":"https://orcid.org/0000-0002-9204-7177","observed_orcids":["https://orcid.org/0000-0002-9204-7177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"TIL ST\u00dcRMER","raw_affiliation_strings":["Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chapel Hill, NC","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7381,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.70932612,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":95},"biblio":{"volume":"72","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5059000253677368,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5059000253677368,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.3903999924659729,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.08510000258684158,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease-and-related-dementias","display_name":"Alzheimer's disease and related dementias","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.9539999961853027},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7770000100135803},{"id":"https://openalex.org/keywords/incident-dementia-risk","display_name":"incident dementia risk","score":0.7059999704360962},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7269999980926514},{"id":"https://openalex.org/keywords/medicare-beneficiaries","display_name":"Medicare beneficiaries","score":0.8939999938011169},{"id":"https://openalex.org/keywords/new-user-cohort","display_name":"new-user cohort","score":0.6320000290870667},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.6769999861717224},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.5649999976158142},{"id":"https://openalex.org/keywords/nursing-home-admission","display_name":"nursing home admission","score":0.6639999747276306},{"id":"https://openalex.org/keywords/propensity-score-matching","display_name":"propensity score matching","score":0.6909999847412109},{"id":"https://openalex.org/keywords/inverse-probability-of-treatment-weighting","display_name":"inverse probability of treatment weighting","score":0.7009999752044678}],"concepts":[{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9359696507453918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8032035231590271},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.6727416515350342},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.49823546409606934},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4735763967037201},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.39966633915901184},{"id":"https://openalex.org/C74909509","wikidata":"https://www.wikidata.org/wiki/Q10387","display_name":"Gerontology","level":1,"score":0.346774160861969},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.19659742712974548},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.1877627968788147},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.13200777769088745}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db23-1802-pub","doi":"https://doi.org/10.2337/db23-1802-pub","is_oa":false,"landing_page_url":"http://dx.doi.org/10.2337/db23-1802-pub","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4390201546","https://openalex.org/W2941817107","https://openalex.org/W4413962436","https://openalex.org/W7126140234","https://openalex.org/W3213733158","https://openalex.org/W4409217570","https://openalex.org/W7117232992","https://openalex.org/W4415260874","https://openalex.org/W4406223884","https://openalex.org/W7164187085"],"abstract_inverted_index":{"Previous":[0],"studies":[1],"suggested":[2],"GLP-1":[3],"receptor":[4],"agonists":[5],"(GLP1RA)":[6],"may":[7],"improve":[8],"cognitive":[9],"function":[10],"and":[11,37,80,97,163,169,176,184,199,214,218,221,226,257,320],"liraglutide\u2019s":[12],"effect":[13],"on":[14],"Alzheimer\u2019s":[15,35],"disease":[16,36],"is":[17,272,284],"being":[18],"evaluated":[19],"by":[20,286],"the":[21,93,103,149,287],"ELAD":[22],"(Evaluating":[23],"Liraglutide":[24],"in":[25,102,130,138,148,216],"Alzheimer's":[26],"Disease)":[27],"clinical":[28],"trial.":[29],"To":[30],"examine":[31],"whether":[32],"liraglutide":[33,182,217,242,271],"decrease":[34],"related":[38],"dementia":[39],"(ADRD)":[40],"risk":[41,166,278],"compared":[42,279],"with":[43,76,251,274,280],"other":[44],"antidiabetics,":[45],"we":[46],"implemented":[47],"an":[48],"active":[49,261],"comparator,":[50,262],"new":[51,263],"user":[52,264],"cohort":[53,265],"design":[54],"identifying":[55],"initiators":[56,180],"of":[57,70,92,100,112,181,194,210,267,291],"liraglutide,":[58],"DPP-4":[59],"inhibitors":[60],"(DPP4i),":[61],"respectively,":[62],"using":[63,172],"a":[64,190,275],"US":[65],"nationwide":[66],"20%":[67],"random":[68],"sample":[69],"fee-for-service":[71],"Medicare":[72],"beneficiaries":[73],"aged":[74],"70+":[75],"parts":[77,113],"A,":[78,114],"B,":[79],"D":[81],"coverage":[82],"from":[83],"2007-2019.":[84],"We":[85,153],"required":[86],"patients":[87,269],"to":[88,117,158,197,202,239,243,380],"have":[89],"2nd":[90],"prescription":[91],"same":[94],"drug":[95,118],"class":[96],"be":[98],"free":[99],"ADRD":[101,121,128,136,211,277],"3-year":[104,109,150],"window":[105],"(during":[106],"which":[107],"requiring":[108],"continuous":[110],"enrollment":[111],"B)":[115],"prior":[116],"initiation.":[119],"The":[120,179],"outcome":[122,258],"was":[123,212,224,235],"defined":[124],"as":[125],"1)":[126],"\u22651":[127,135],"claims":[129,137],"1":[131],"year":[132,140],"AND":[133],"2)":[134],"another":[139],"or":[141],"nursing":[142],"home":[143],"stay":[144],"\u2265":[145],"6":[146],"months":[147],"follow-up":[151],"period.":[152],"estimated":[154,164],"propensity":[155],"scores":[156],"(PS)":[157],"balance":[159],"confounders":[160],"across":[161,248],"cohorts":[162],"adjusted":[165],"difference":[167],"(RD)":[168],"95%":[170],"CI":[171],"inverse":[173],"probability":[174],"treatment":[175],"censoring":[177],"weight.":[178],"(n=1260)":[183],"DPP4i":[185],"(n=15952)":[186],"were":[187,246],"followed":[188],"for":[189],"median":[191],"(IQR)":[192],"duration":[193,290],"3.0":[195,200],"(2.0":[196],"3.0)":[198,203],"(1.7":[201],"years,":[204],"respectively.":[205,231],"During":[206],"follow-up,":[207],"incident":[208,222],"cases":[209],"196":[213],"3215":[215],"DPP4i,":[219],"respectively;":[220],"rate":[223],"63":[225],"85":[227],"per":[228],"1000":[229],"person-years,":[230],"Adjusted":[232],"RD":[233],"(%)":[234],"-4.4":[236],"(95%CI":[237],"-6.6":[238],"-2.39)":[240],"comparing":[241],"DPP4i.":[244],"Results":[245],"consistent":[247],"sensitivity":[249],"analyses":[250],"varying":[252],"exclusion":[253],"criteria,":[254],"baseline":[255],"period,":[256],"definitions.":[259],"Our":[260],"study":[266,283],"older":[268],"showed":[270],"associated":[273],"decreased":[276],"alternatives.":[281],"This":[282],"limited":[285],"relatively":[288],"short":[289],"treatments.":[292],"Disclosure":[293],"T.Wang:":[294],"None.":[295,367],"J.B.Buse:":[296],"Consultant;":[297],"Alkahest,":[298],"Anji":[299],"Pharmaceuticals,":[300,327,360],"AstraZeneca,":[301],"Bayer":[302],"Inc.,":[303,306,315,325,328,347,354,361],"Biomea":[304],"Fusion,":[305],"Boehringer":[307],"Ingelheim":[308],"International":[309],"GmbH,":[310],"CeQur":[311],"SA,":[312],"Cirius":[313],"Therapeutics,":[314,317,332,351,358],"Corcept":[316],"Eli":[318],"Lilly":[319],"Company,":[321],"GentiBio,":[322],"Glycadia,":[323],"Glyscend":[324,353],"Janssen":[326],"Mellitus":[329,355],"Health,":[330,336,356],"Pendulum":[331,357],"Praetego,":[333,362],"LLC,":[334,363],"Stability":[335,364],"Terns,":[337],"Inc,":[338],"Valo,":[339],"Other":[340],"Relationship;":[341],"Novo":[342,348,371],"Nordisk,":[343,349,372],"Research":[344],"Support;":[345],"Dexcom,":[346],"vTv":[350],"Stock/Shareholder;":[352,369],"PhaseBio":[359],"Health.":[365],"V.Pate:":[366],"T.St\u00fcrmer:":[368],"Novartis,":[370],"Roche":[373],"Pharmaceuticals.":[374],"Funding":[375],"American":[376],"Diabetes":[377],"Association":[378],"(4-22-PDFPM-06":[379],"T.W.)":[381]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-06-24T00:00:00"}